Abstract
Among the requirements set by anesthesiologists for new neuromuscular blocking agents, high selectivity of the action on end-plate acetylcholine receptors is one of the most important. Unfortunately, the majority of the known neuromuscular blocking agents, in addition to their main action, may also affect other biologic substrates adapted to the interaction with acetylcholine, such as nicotinic and muscarinic receptors of the autonomic nervous system as well as cholinesterases. Neuromuscular blocking agents with such activity can cause various side effects (changes of hemodynamics, heart rate, etc.).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrachams VC, Hilton SM (1962) Blocking action of decamethonium at different sites in the autonomic nervous system of the cat. Br J Pharmacol 18:194–203
Alyautdin RN, Buyanov VV, Fisenko VP, Lemina EYu, Muratov VK, Samoilov DN, Shorr VA (1980) On some properties of a new steroid curare-like compound pipecurium bromide. Arzneimittelforsch 30(I), 2a:355–357
Ardamatskaya AN (1957) Surgical experience with succinylcholine (in Russian). In: Ditilin i opyt ego klinicheskogo primeneniya. Armenian SSR Academy of Sciences Publishers, Yerevan, pp 178–181
Artusio JF, Murbury BE, Grews MA (1951) A quantitative study of d-tubocurarine, tri-(ethylaminoethoxy)-1,2,3-benzene (Flaxedil) and a series of tri-methyl and dimethyl-ethylammonium compounds in anaesthetized man. Ann NY Acad Sci 54,3:512–527
Arunlakshana O, Shild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58
Baraka A (1967) A comparative study between diallylnortoxiferine and tubocurarine. Br J Anaesth 39:624–629
Benfey BG, Yong MS, Belleau B, Melchiorre C (1979) Cardiac muscarinic blocking and atropine blocking effects of tetramine disulfide with α-adrenoreceptor blocking activity. Can J Physiol Pharmacol 57:41–47
Bieger D, Lüllmann H, Wassermann O (1968) Über eine akute Anti-Acetylcholin-Wirkung von Hemicholinium No. 3 am Vorhof des Meerschweinschens. Naunyn Schmidebergs Arch Pharmacol 259:386–393
Birdsall NJM, Burgen ASV, Hulme EC, Stockton JM (1981) Gallamine regulates muscarinic receptors in the heart and cerebral cortex. Br J Pharmacol 74:798P
Biró K, Kárpáti E (1981) The pharmacology of new short-acting non-depolarizing muscle relaxant steroid (RGH-4201). Arzneimittelforsch 31:1918–1924
Björklund A, Cegrell L, Flack B, Ritzen M, Rosengren E (1970) Dopamin-containing cells in sympathetic ganglia. Acta Physiol Scand 78:334–338
Bonta IL, Buckett WR, Lewis JJ, Vargaftig BB (1966) 2β,16β-dipiperidino-5-androstane-3,17β-diol-diacetatedimethobromide (NA-97) a potent neuromuscular blocking steroid. In: Second International Congress of Steroids, Milan. Excerpta Medica, Amsterdam. Abstracts, p 344
Bonta IL, Goorissen EM, Derkx FH (1968) Pharmacological interaction between pancuronium bromide and anaesthetics. Eur J Pharmacol 4:83–90
Booij LHDJ, Vree TB, Crul JF (1982) Org NC 45: a new steroidal non-depolarizing muscle relaxant. Pharm Weekbl [Sci] 4:1–4
Boros M, Szenohradszky J, Marosi Gy, Toth J (1980) Comparative clinical study of pipecurium bromide and pancuronium bromide. Arzneimittelforsch 30, 2a:389–393
Bourne JC, Collier HOS, Somers GF (1952) Succinylcholine (Succinoylcholine): muscle relaxant of short action. Lancet 1:1225–1229
Bovet D, DEpierre F, Courvoisier S, Lestrange Y (1949) Recherches sur les poisons curarisants de synthèse. IIme Partie. Ethers phénoliques à fonction ammonium quaternaire. Action du tri-iodoéthylate de tri(diéthylaminoéthoxy)benzène (2559 F). Arch Int Pharmacodyn Ther 80:172–188
Bowman WC (1982) Non-relaxant properties of neuromuscular blocking drugs. Br J Anaesth 54:147–160
Brittain RT, Tyers MB (1973) The pharmacology of AH 8165: a rapid-acting, short-lasting, competitive neuromuscular blocking drug. Br J Anaesth 45:837–843
Brittain RT, Jack D, Tyers MB (1977) Pharmacological and certain chemical properties of AH 10407. An unusually short-acting, competitive neuromuscular blocking drug, and some related compounds. Br J Pharmacol 61:47–55
Brown BR, Crout JR (1966) Mechanism of the positive inotropic effect of gallamine on guinea pig heart muscle. Fed Proc 25:472
Brown BR, Crout JR (1968) The sympathomimetic effect of gallamine on the heart. Anesthesiology 29:179–180
Brown BR, Crout JR (1970) The sympathomimetic effect of gallamine on the heart. J Pharmacol Exp Ther 172:266–273
Brown DA (1980) Locus and mechanism of action of ganglion-blocking agents. In: Kharkevich DA (ed) Pharmacology of ganglionic transmission. Springer, Berlin Heidelberg New York, pp 185–235
Brücke F (1956) Dicholinesters of α,ω-dicarboxylic acids and related substances. Pharmacol Rev 8:265–335
Buckett WR, Saxena PR (1969) The pharmacology of dacuronium bromide — a new short-acting neuromuscular blocking drug of non-depolarizing type. In: Proceedings of the 4th International congress of pharmacology, Basel, 14–18 July, p 420
Buckett WR, Marjoribanks CEB, Marwick FA, Morton MB (1968) The pharmacology of pancuronium bromide (Org NA97), a new potent steroidal neuromuscular blocking agent. Br J Pharmacol 32:671–682
Bülbring E, Depierre F (1949) The action of synthetic curarizing compounds on skeletal muscle and sympathetic ganglia, both normal and denervated. Br J Pharmacol 4:22–32
Bunatyan AA, Mikheev VI (1980) Clinical experience with new steroid muscle relaxant: pipecurium bromide. Arzneimittelforsch 30, 2a:383–385
Burstein CL, Jackson A, Bishop HF, Rovenstine EA (1950) Curare in the management of autonomic reflexes. Anesthesiology 11:409–421
Butaev BM (1953) Pharmacological study of paramionum, a new synthetic curare-like agent (in Russian). Cand Med Sci Thesis, Leningrad
Chappie DJ, Enderby DH, Hughes R, Payne JP (1976) Neuromuscular and cardiovascular studies with dimethyl tubocurarine in anaesthetized cats, rhesus monkeys and man. Br J Pharmacol 56:354P–355P
Clark AL, Mitchelson F (1976) The inhibitory effect of gallamine on muscarinic receptors. Br J Pharmacol 58:323–331
Coleman AJ, Downing JW, Leary WP, Moyes DG, Styles M (1972) The immediate cardiovascular effects of pancuronium, alcuronium, and tubocurarine in man. Anaesthesia 27:415–422
Coleman AJ, O’Brien A, Downing JW, Jeal DE, Moyes DG, Leary WP (1973) AH 8165: a new non-depolarizing muscle relaxant. Anaesthesia 28:262–267
Collier HOJ, Hall RA (1950) Pharmacology of d-OO-dimethyl tubocurarine iodide in relation to its clinical use. Br Med J I:1293–1295
Crul JF, Booij LHDJ (1980) First clinical experiences with Org NC 45. Br J Anaesth 52, Suppl 1:49S–52S
Danilov AF, Mikhelson MYa, Rybolovlev RS (1957) Pharmacological properties of succinylcholine and clinical experience with it (in Russian). In: Ditilin i opyt ego klinicheskogo primeneniya. Armenian SSR Academy of Sciences Publishers, Yerevan, pp 92–107
Danilov AF, Malygin W, Starshinova LA, Khromov-Borisov NV, Torf SF, Cherepanova VP (1979) Tercuronium — a new nondepolarizing muscle relaxant with high activity and selectivity of the effect (in Russian). Farmakol Toksikol 5:478–481
Darbinyan TM, Saliev RSh, Shloznikov BM, Saakyan ES (1980) Haemodynamics during various kinds of combined induction anaesthesia using antidepolarizing muscle relaxants for tracheal intubation (in Russian). Anesteziol Reanimatol 5:7–11
Degtyareva LG, Mikhelson VA (1964) Clinical experience with domestic neuromuscular blocking agent qualidil (in Russian). Eksp Khir Anesteziol 6:88–91
Docherty JR, McGrath JC (1978) Sympathomimetic effects of pancuronium bromide on the cardiovascular system of the pithed rat: a comparison with the effects of drugs blocking the neuronal uptake of noradrenaline. Br J Pharmacol 64:589–599
Docherty JR, McGrath JC (1980) A comparison of the effects of pancuronium bromide and its monoquaternary analogue, Org NC 45, on autonomic and somatic neurotransmission in the rat. Br J Pharmacol 71:225–233
Doughty AG, Wylie WD (1951) An assessment of flaxedil (Gallamine triethiodide; B.P.). Proc R Soc Med 44:375–386
Drane SE, Evans MH (1979) The relative vagolytic potencies of six muscle relaxants in the rabbit. J Pharm Pharmacol 31:864–866
Durant NN, Bowman WC, Marshall IG (1977) A comparison of the neuromuscular and autonomic blocking activities of (+)-tubocurarine and its N-methyl and O,O,N-trimethyl analogues. Eur J Pharmacol 46:297–302
Durant NN, Marshall IG, Savage DS, Nelson DN, Sleigh T, Carlyle IC (1979) The neuromuscular and autonomic blocking activities of pancuronium, Org NC 45 and other pancuronium analogues. J Pharm Pharmacol 31, 12:831–836
Eckfeld DK (1959) Curarizing and atropine-like properties of bis-atropinium and bis-scopolaminium compounds. J Pharmacol Exp Ther 126:21–23
Eisele JH, Marta JA, Davis HS (1971) Quantitative aspects of the chronotropic and neuromuscular effects of gallamine in anesthetized man. Anesthesiology 35:630–633
Elwell LH (1960) Effects of d-tubocurarine on the submandibular salivary gland. Am J Physiol 198:621–624
Famewo CE (1981) Clinical trial of fazadinium bromide (fazadon). Can Anaesth Soc J 28:149–152
Firsov AA, Zhilis BG, Stazhadze LL (1970) Anesthesiological experience with a neuromuscular blocking agent cyclobutonium (in Russian). In: Kharkevich DA (ed) Novye kurarepodobnye i ganglioblokiruyushchie sredstva (New curare-like and ganglion-blocking agents). Meditsina, Moscow, pp 152–159
Flacke W, Gillis RA (1968) Impulse transmission via nicotinic and muscarinic pathways in the stellate ganglion of the dog. J Pharmacol Exp Ther 163:266–276
Foldes FF, Machaj TS, Carberry PC (1954) The use of gallamine triethiodide (Flaxedil) with pentothal-sodium nitrous oxide-oxygen anesthesia in abdominal surgery. Anaesth Analg 33:122–128
Foldes FF, Swerdlow M, Liphschitz E, Hees GR, Shanor SP (1956) Comparison of the respiratory effects of suxamethonium and suxaethonium in man. Anesthesiology 17:559–568
Foldes FF, Wolfson B, Sokoll M (1961) The use of toxiferine for the production of surgical relaxation. Anesthesiology 22:93–99
Frey R, Seeger R (1961) Experimental and clinical experience with toxiferine (alkaloid of calabash curare). Can Anaesth Soc J 8:99–117
Fuder H, Meiser C, Wormstall H, Muscholl E (1981) The effects of several muscarinic antagonists on pre- and postsynaptic receptors in the isolated rabbit heart. Naunyn Schmiedebergs Arch Pharmacol 316:31–37
Gandiha A, Marshall IG, Paul D, Singh H (1974) Neuromuscular and other blocking actions of a new series of mono and bis quaternary aza steroids. J Pharm Pharmacol 26:871–877
Gandiha A, Marshall IG, Paul D, Rodger IW, Scott W, Singh H (1975) Some actions of chandonium iodide, a new shrot-acting muscle relaxant, in anaesthetized cats and on isolated muscle preparations. Clin Exp Pharmacol Physiol 2:159–170
Gardier RW, Ganansia M-F, Delaunois AL, Hamelberg W (1974) Enhancement of ganglionic muscarinic activity by gallamine. Anesthesiology 40:494–497
Gardier RV, Tsevdos EJ, Jackson DB (1978) The effect of pancuronium and gallamine on muscarinic transmission in the superior cervical ganglion. J Pharmacol Exp Ther 204:46–53
Goat VA, Feldman SA (1971) Action of muscle relaxant drugs on cardiac cholinergic receptors in the isolated rabbit heart. Br J Anaesthesiol 43:203–204
Greengard P, Kebabian JW (1974) Role of cyclic AMP in synaptic transmission in the mammalian peripheral nervous system. Fed Proc 33:1059–1067
Gross EG, Cullen SC (1945) The action of curare on the smooth muscle of the small intestine and on the blood pressure. Anesthesiology 6:231–238
Grossman E, Jacobi AM (1974) Hemodynamic interaction between pancuronium and morphine. Anesthesiology 40:299–301
Guyton AC, Reeder RC (1950) Quantitative studies on the autonomic actions of curare. J Pharmacol Exp Ther 98:188–194
Hald T, Mygind T (1967) Effect of curare on canine micturition. J Urol 97:101–104
Harrison GA (1972) The cardiovascular effects and some relaxant properties of four relaxants in patients about to undergo cardiac surgery. Br J Anaesth 44:485–494
Hoppe JO, Funnel JE, Lape H (1955) The effects of structural variation in the quaternary nitrogen centers of benzoquinonium chloride upon neuromuscular blocking activity. J Pharmacol Exp Ther 115:106–119
Hughes R (1970) Haemodynamic effects of tubocurarine, gallamine, and suxamethonium in dogs. Br J Anaesth 42:928–934
Hughes R (1972) Evaluation of the neuromuscular blocking properties and side-effects of the two new isoquinolinium bisquaternary compounds (BW252C64 and BW403C65). Br J Anaesth 44:27–41
Hughes R, Chappie DJ (1976 a) Effects of non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats. Br J Anaesth 48:59–68
Hughes R, Chappie DJ (1976 b) Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys. Br J Anaesth 48:847–852
Hughes R, Chappie DJ (1981) The pharmacology of atracurium: a new competitive neuromuscular blocking agent. Br J Anaesth 53:31–44
Hughes R, Ingram GS, Payne JP (1976 a) Studies on dimethyltubocurarine in anaesthetized man. Br J Anaesth 48:969–974
Hughes R, Payne JP, Sugai N (1976 b) Studies on fazadinium bromide. (AH 8165): a new non-depolarizing neuromuscular blocking agent. Can Anaesth Soc J 23:36–47
Ivankovich AD, Miletich DJ, Albrecht RF, Zahed B (1975) The effect of pancuronium on myocardial contraction and catecholamine metabolism. J Pharm Pharmacol 27:837–841
Johnstone M, Mahmoud AA, Mrozinski RA (1978) Cardiovascular effects of tubocurarine in man. Anaesthesia 33:587–593
Kajimoto N (1970) Pharmacology of alloferin (diallyl-bis-nortoxiferine). Acta Sch Med Univ Kyoto 40:291–304
Kárpáti E, Biró K (1980) Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide. Arzneimittelforsch 30, 2a:346–354
Kelman GR, Kennedy BR (1971) Cardiovascular effects of pancuronium in man. Br J Anaesth 43:335–338
Kennedy BR, Farman JV (1968) Cardiovascular effects of gallamine triethiodide in man. Br J Anaesth 40:773–780
Kennedy BR, Kelman GR (1970) Cardiovascular effects of alcuronium in man. Br J Anaesth 42:625–630
Kensler CJ, Zirkle CL, Matallana A, Condouris GJ (1954) The selective anticholinergic activity of aliphatic tris-quaternry ammonium compounds. J Pharmacol Exp Ther 112:210–219
Kharkevich DA (1956) Alteration of lability of the superior cervical ganglion under the influence of quaternary ammonium bases (in Russian). Byull Eksp Biol Med 10:34–38
Kharkevich DA (1957) The effect of cholinolytic agents on the functional lability of the superior cervical ganglion (in Russian). Byull Eksp Biol Med 12:70–76
Kharkevich DA (1962) Ganglionarnye sredstva (Ganglionic agents). Medgiz, Moscow
Kharkevich DA (1965) On the pharmacological properties of a new curare-like agent anatruxonium (in Russian). Farmakol Toksikol 3:305–309 or (1966) Fed Proc 25:T521–T523
Kharkevich DA (1966) On the pharmacological properties of a new curare-like agent anatruxonium (in Russian). Fed Proc 25:T521–T523
Kharkevich DA (1966) On the pharmacology of a new nondepolarizing muscle relaxant cyclobutonium (in Russian). Farmakol Toksikol 1:47–53
Kharkevich DA (1970 a) On curare-like activity of decadonium diiodide (in Russian). Farmakol Toksikol 4:395–399
Kharkevich DA (1970 b) On the pharmacological properties of a new antidepolarizing curare-like agent diadonium diiodide (in Russian). Farmakol Toksikol 5:531–536
Kharkevich DA (1970 c) Pharmacology of new antidepolarizing agents — anatruxonium, truxilonium, cyclobutonium and pyrocyclonium (in Russian). In: Kharkevich DA (ed) Novye kurarepodobnye i ganglioblokiruyushchie sredstva (New curare-like and ganglion-blocking agents). Meditsina, Moscow, pp 41–47
Kharkevich DA (1973) Curare-like agents (in Russian). In Kharkevich DA (ed) Uspekhi v sozdanii novykh lekarstvennykh sredstv (Progress in the design of new drugs). Meditsina, Moscow, pp 138–187
Kharkevich DA (1974) On predominant action of a number of pharmacological agents on cardiac m-cholinoreceptors (in Russian). Farmakol Toksikol 9:94–102
Kharkevich DA (ed) (1983) New neuromuscular blocking agents. Meditsina, Moscow
Kharkevich DA, Kravchuk LA (1961) On the pharmacology of a new curare-like agent truxilonium (in Russian). Farmakol Toksikol 3:318–324
Kharkevich DA, Shorr VA (1980) Cardiotropic antimuscarinic action of some curare-like agents. Arch Int Pharmacodyn Ther 248:238–250
Kharkevich DA, Skoldinov AP, Samoilov DN, Shorr VA (1981) The effects of anticholinergic agents on muscarinic receptors of different localization. In: Pepeu G, Ladinsky H (eds) Cholinergic mechanisms. Phylogenetic aspects, central and peripheral synapses, and clinical significance. Plenum, New York, pp 351–365
Kimura KK, Unna K (1950) Curare-like action of decamethylene-bis(atropinium iodide). J Pharmacol Exp Ther 98:286–292
Klupp H, Kraupp O, Stormann H, Stumpf Ch (1953) Über die pharmakologischen Eigenschaften einiger Polymethylen-Dicarbaminsäure-bischolinester. Arch Int Pharmacodyn Ther 96:161–182
Klusha VE, Kimenis AA, Sokolov GP (1970) The results of pharmacological and clinical study of a new domestic neuromuscular blocking agent dioxonium (in Russian). In: Eksperimentalnaya i klinicheskaya farmakoterapiya, 2 (Experimental and clinical pharmacotherapy). Zinatne, Riga, pp 55–74
Kotomina GL (1970) Comparative clinical evaluation of new neuromuscular blocking agents of the group of diphenylcyclobutanedicarboxylic acids’ derivatives (in Russian). In: Kharkevich DA (ed) Novye kurarepodobnye i ganglioblokiruyushchie sredstva (New curare-like and ganglion-blocking agents). Meditsina, Moscow, pp 83–90
Kotomina GL, Kharkevich DA (1968) Clinical pharmacological characteristics of a domestic neuromuscular blocking agent anatruxonium (in Russian). Khirurgiya 4:23–28
Kraupp O, Klupp H, Stormann H, Stumpf Ch (1954) Cholinesterasehemmungswirkung und neuromuskuläre Wirksamkeit von Bischolin-Polymethylendicarbaminsäureestern. Arch Exp Pathol Pharmakol 222:180–182
Kuhnen-Clausen D (1970) Investigations on the parasympatholytic effect of toxogonin on the guinea-pig isolated ileum. Eur J Pharmacol 9:85–92
Lee C, Yang E, Lippmann M (1980) Constrictive effect of pancuronium on capacitance vessels. Br J Anaesth 52:261–263
Lee Son S, Waud BE (1977) Potencies of neuromuscular blocking agents at the receptors of atrial pacemaker and the motor end-plate of the guinea-pig. Anestesiology 47:34–36
Lee Son S, Waud DR (1978) A vagolytic action of neuromuscular blocking agents at the pacemaker of the isolated guinea pig atrium. Anesthesiology 48:191–194
Lee Son S, Waud DR (1980) Effects of non-depolarizing neuromuscular blocking agents on the cardiac vagus nerve in the guinea pig. Br J Anaesth 52:981–987
Lee Son S, Waud BE, Waud DR, Phil D (1981) A comparison of neuromuscular blocking and vagolytic effects of Org NC 45 and pancuronium. Anesthesiology 55:12–18
Lemina EYu (1978) Farmakologiya novykh kurarepodobnykh sredstv dipironiya i amidoniya (Pharmacology of new curare-like agents dipyronium and amidonium). Cand Med Sci Thesis, Moscow, 1st Medical Institute
Leong W, Given JB, Little DM (1962) The clinical use of imbretil. Can Anaesth Soc J 9:312–318
Leung E, Mitchelson F (1982) The interaction of pancuronium with cardiac and ileal muscarinic receptors. Eur J Pharmacol 80:1–9
Li CK, Mitchelson F (1978) The effect of stercuronium on cardiac muscarinic receptors. Eur J Pharmacol 51:251–259
Li CK, Mitchelson F (1980) The selective antimuscarinic action of stercuronium. Br J Pharmacol 70:313–321
Libert B, Tosaka T (1970) Dopamine as a synaptic transmitter and modulator in sympathetic ganglia. A different mode of synaptic action. Proc Natl Acad Sci USA 67:667–673
Loh L (1970) The cardiovascular effects of pancuronium bromide. Anaesthesia 25:356–363
Longnecker DE, Stoleting RK, Morrow AG (1973) Cardiac and peripheral vascular effects of gallamine. Anaesth Analg 52:931–935
Lüllmann H, Ohnesorge FK, Shauwecker G-C, Wassermann O (1969) Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds. Eur J Pharmacol 6:241–247
Macmillan RR, West DM, Williams NE, Calvey TN (1983) Effects of atracurium on neuromuscular transmission. Br J Clin Pharmacol 15:P154–P155
Madden J, Mitchelson F (1975) The interaction of hemicholinium-3 (HC-3) with cholinomimetics and atropine. Eur J Pharmacol 32:17–29
Marshall IG (1973) The ganglion-blocking and vagolytic actions of three short-acting neuromuscular blocking drugs in the cat. J Pharm Pharmacol 25:530–536
Marshall IG (1980) Actions of non-depolatizing neuromuscular blocking agents at cholinoceptors other than at the motor endplate. In: Curares and curarization. Excerpta Medica, Amsterdam, pp 257–274
Marshall IG, Paul D, Singh H (1973) The neuromuscular and other blocking actions of 4,17a-dimethyl-4,17a-diaza-d-homo-5a-androstane dimethiodide (HS-342) in the anaesthetized cat. Eur J Pharmacol 22:129–134
Marshall IG, Agoston S, Booij LHDJ, Durant NN, Foldes FF (1980) Pharmacology of Org NC 45 compared with other non-depolarizing neuromuscular blocking drugs. Br J Anaesth 52, Suppl 1:11S–19S
Marshall IG, Harvey AL, Singh H, Bhardwaj TR, Paul D (1981) The neuromuscular and autonomic blocking effects of azosteroids containing choline or acetylcholine fragments. J Pharm Pharmacol 33:451–457
Marshall RJ, Ojewole JAO (1979) Comparison of the autonomic effects of some currently used neuromuscular blocking agents. Br J Pharmacol 66:77–78
Marshall RJ, McGrath JC, Miller RD, Docherty JR, Lamar J-C (1980) Comparison of the cardiovascular actions of Org NC 45 with those produced by other non-depolarizing neuromuscular blocking agents in experimental animals. Br J Anaesth 52, Suppl 1:21S–31S
Mashkovsky MD, Briskin AI (1952) Pharmacological properties of a new curare-like drug “diplacine” (in Russian). Farmakol Toksikol 5:24–32
Mashkovsky MD, Medvedev BA (1960) On the pharmacology of symmetrical bis-quaternary derivatives of 9-methyl-3,9-diazobicyclo-(3,3,1)-nonane (in Russian). Farmakol Toksikol 6:493–499
Mashkovsky MD, Sadritdinov F (1962) Curare-like properties of 1,6-di-(3,3-benzylquinuclidyl-1,1)-hexane dichloride (Qualidil) (in Russian). Farmakol Toksikol 6:685–691
Matsuki A, Kothary SP, Zsigmond EK (1973) Effects of gallamine on plasma Cortisol and catecholamine levels in man. Can Anaesth Soc J 20:539–545
Mautner H, Luisada A (1941) Antagonistic effect of asphyxia to curare paralysis of the vagus nerve. J Pharmacol Exp Ther 72:386–393
McCullough LS, Rier CE, Delaunois AL, Gardier RW, Hamelberg W (1970) The effect of d-tubocurarine on spontaneous postganglionic sympathetic activity and histamine release. Anesthesiology 33:328–334
McCullough LS, Stone WA, Delaunois AL, Rier CE, Hamelberg W (1972) The effect of dimethyl tubocurarine iodide on cardiovascular parameters, postganglionic sympathetic activity and histamine release. Anaesth Analg 51:554–559
Mcintosh FC, Paton WDM (1949) The liberation of histamine by certain organic bases. J Physiol (Lond) 109:190–219
Medvedev BA (1962) Comparative study of neuromuscular blocking and other pharmacological properties of 1,4-bis[9-methyl-3,9-diazabicyclo-(3,3,1)-nonano-3]butane diiodomethylate and dimethylsulphomethylate (in Russian). Farmakol Toksikol 3:320–326
Miller RD, Eger EI II, Stevens WC, Gibbons K (1975) Pancuronium-induced tachycardia in relation to alveolar halothane, dose of pancuronium, and prior atropine. Anesthesiology 42:352–355
Mitchelson F (1971) Differentiation between the actions of acetylcholine and tetramethylammonium on the isolated taenia of the guinea-pig caecum by hemicholinium-3. Br J Pharmacol 42:43–55
Morgenstern C, Splinth G (1965) Untersuchungen über die Ursachen der Gallamintachykardie und ihre antagonistische Beeinflussung durch Beta-Adrenolytica. Anaesthesist 14:298–301
Munger WL, Miller RD, Stevens WC (1974) The dependence of d-tubocurarine-induced hypotension on alveolar concentration of halothane, dose of d-tubocurarine, and nitrous oxide. Anesthesiology 40:442–448
Murbury BE, Artusio JE, Wescoe WC, Riker WF (1951) The effects of synthetic curarelike compound tri-iodo salt of tris-(triethylaminoethoxy)-1,2,3-benzene (Flaxedil) on the anaesthetized surgical patients. J Pharmacol Exp Ther 103:280–287
Mushin WW, Wien R, Mason DFJ, Langston GT (1949) Curare-like action of tri-(diethylaminoethoxy)-benzene triethiodide. Lancet 1:726–728
Nana A, Cardan E, Domokos M (1973) Blood catecholamine changes after pancuronium. Acta Anaesth Scand 17:83–87
Ostrovsky VYu, Kiselev SO (1980) Anesthesiological experience with diadonium (in Russian). Anesteziol Reanimatol 4:7–10
Paton WDM (1949) The pharmacology of curare and curarizing substances. J Pharm Pharmacol 1:273–286
Paton WDM (1957) Histamine release by compounds of simple chemical structure. Pharmacol Rev 9:269–328
Paton WDM (1959) The effects of muscle relaxants other than muscular relaxation. Anesthesiology 20:453–463
Payne JP, Hughes R (1981) Evaluation of atracurium in anaesthetized man. Br J Anaesth 53:45–54
Pelikan EW, Unna KR (1952) The functional importance of the quaternary nitrogen atoms in Flaxedil. J Pharmacol Exp Ther 104:354–362
Quintana A (1977) Effect of pancuronium bromide on the adrenergic reactivity of the isolated rat vas deferens. Eur J Pharmacol 46:275–277
Qvist TF, Lang-Jensen T, Korshin JD, Skovsted P (1980) The cardiovascular effects of pancuronium during halothane and cyclopropane anaesthesia. Acta Anaesth Scand 24:415–418
Rathbun FJ, Hamilton JT (1970) Effect of gallamine on cholinergic receptors. Can Anaesth Soc J 17:574–590
Riker WF, Wescoe WC (1951) The pharmacology of flaxedil, with observations on certain analogs. Ann NY Acad Sci 54:373–394
Saito S, Aviado DM (1963) Pharmacological studies of hexamethylene-bis-carbaminoylcholine (Imbretil) on the cardiovascular and respiratory systems in dogs. Jpn Circ J 27:791–796
Salmenperä M, Tammisto T (1980) The use of dioxonium as a neuromuscular blocking agent. Acta Anaesth Scand 24:395–398
Salt PJ, Barnes PK, Conway CM (1980) Inhibition of neuronal uptake of noradrenaline in the isolated perfused rat heart by pancuronium and its homologues, Org 6368, Org 7268, and NC 45. Br J Anaesth 52:313–317
Samoilov DN (1971 a) Chemical structure and cholinolytic activity of bis-quaternary ammonium derivatives of truxillic acids (in Russian). Farmakol Toksikol 4:413–420
Samoilov DN (1971 b) On the chemical structure and ganglion blocking activity of truxillic acid derivatives (in Russian). Farmakol Toksikol 5:544–549
Savarese JJ (1979) The autonomic margins of safety of metocurine and d-tubocurarine in the cat. Anesthesiology 50:40–46
Savarese JJ, Ali HH, Antonio RP (1977) The clinical pharmacology of metocurine: Dimethyltubocurarine revisited. Anesthesiology 47:277–284
Saxena PR, Bonta IL (1970) Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors. Eur J Pharmacol 11:332–341
Segarra Domenech J, Santafe Oroz R, Rodriguez Sasiain JM, Quintana Loyola A, Santafe Oroz J (1976) Pancuronium bromide: An indirect sympathomimetic agent. Br J Anaesth 48:1143–1148
Sheth V, Iabuis II (1980) Comparison of cardiovascular effect of pancuronium bromide with d-tubocurarine and gallamine. Indian J Anaesth 28:42–50
Shorr VA (1972) On the action of curare-like agents on some acetylcholine effects (in Russian). Farmakol Toksikol 4:426–431
Shorr VA (1975) On the peculiarities of action of neuromuscular blocking agents on m-cholinoreceptors of various localizations (in Russian). Farmakol Toksikol 1:38–43
Smith G, Proctor DW, Spence AA (1970) A comparison of some cardiovascular effects of tubocurarine and pancuronium in dogs. Br J Anaesth 42:923–927
Smith NT, Whitcher CE (1967) Hemodynamic effects of gallamine and tubocurarine administered during halothane anesthesia. JAMA 199:704–708
Stenlake JB, Waigh RD, Urwin J, Dewar GH, Hughes R, Chappie DJ (1981 a) Bis-3,4-dihydroisoquinolinium salts as potential neuromuscular blocking agents. Eur J Med Chem 16:503–507
Stenlake JB, Waigh RD, Urwin J, Dewar GH, Hughes R, Chappie DJ (1981 b) Biodegradable neuromuscular blocking agents. Eur J Med Chem 16:508–514
Stenlake JB, Waigh RD, Dewar GH, Hughes R, Chappie DJ, Coker GG (1981 c) Biodegradable neuromuscular blocking agents. Part 4. Atracurium Besylate and related polyalkylene di-esters. Eur J Med Chem 16:515–524
Stoelting RK (1972) The hemodynamic effects of pancuronium and d-tubocurarine in anaesthetized patients. Anesthesiology 36:612–615
Stoelting RK (1973) Hemodynamic effects of gallamine during halothane-nitrous oxide anaesthesia. Anesthesiology 39:645–647
Stoelting RK, Longnecker DE (1972) Effect of promethazine on hypotension following d-tubocurarine use in anaesthetized patients. Anesth Analg 51:509–516
Sugrue MF, Duff N, McIndewar I (1975) On the pharmacology of Org 6368 (2β,16β-dipiperidino-5α-androstan-3α-ol acetate dimethobromide), a new steroidal neuromuscular blocking agent. J Pharm Pharmacol 27:721–727
Tammisto T, Welling I (1969) The effect of alcuronium and tubocurarine on blood pressure and heart rate: a clinical comparison. Br J Anaesth 41:317–322
Teerapong P, Marshall IG, Harvey AL, Singh H, Paul D, Bhardwaj TR, Ahuja NK (1979) The effects of dihydrochandonium and other chandonium analogues on neuromuscular and autonomic transmission. J Pharm Pharmacol 31:521–528
Thesleff E (1952) Succinylcholine iodide. Studies on its pharmacological properties and clinical use. Acta Physiol Scand 27, Suppl 99:103–129
Thomas ET (1963) The effect of gallamine triethiodide on blood pressure. Anaesthesia 18:316–323
Tomlinson DR (1979) On the mechanism of pancuronium-induced supersensitivity to noradrenaline in rat smooth muscle. Br J Pharmacol 65:473–478
Unna KR, Pelikan EW, Macfarlane DW, Cazort RJ, Sadove MS, Nelson JT, Drucker AP (1950 a) Evaluation of curarizing drugs in man. I. Potency, duration of action and effects on vital capacity of d-tubocurarine, dimethyl-d-tubocurarine and decamethylenebis(trimethylammonium bromide). J Pharmacol Exp Ther 98:318–329
Unna KR, Pelikan EW, Macfarlane DW, Sadove MS (1950 b) Evaluation of curarizing drugs in man. IV. Tri-(diethylaminoethoxy)-1,2,3-benzene (Flaxedil). J Pharmacol Exp Ther 100:201–209
Valdman AV, Ivanova ZN, Kharkevich DA (1955) The effect of diplacine on the transmission in various links of reflex arch (in Russian). Farmakol Toksikol 2:3–11
Vercruysse P, Bossuyt P, Hanegreefs G, Verbeuren TJ, Vanhoutte PM (1979) Gallamine and pancuronium inhibit pre- and post-junctional muscarinic receptors in canine saphenous veins. J Pharmacol Exp Ther 209:225–230
Volikov AA (1954) Clinical use of domestic curare-like agents during intratracheal gas and ether anaesthesia (in Russian). Vestn Khir 8:10–18
Walts LE, Prescott FS (1965) The effects of gallamine on cardiac rhythm during general anesthesia. Anaesth Analg 44:265–269
Waser P, Harbeck P (1959) Erste klinische Anwendung der Calebassenalkaloide Toxiferin I und Curarin I. Anaesthetist 8:193–198
Wong KC, Wyte SR, Martin WE, Crawford EW (1971) Antiarrhythmic effects of skeletal muscle relaxants. Anesthesiology 34:458–462
Zyablina TF (1959) The use of diplacine during intrathoracic operations in pulmonary tuberculosis patients (in Russian). Vestn Khir 11:112–116
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kharkevich, D.A., Shorr, V.A. (1986). Antimuscarinic and Ganglion-Blocking Activity of Neuromuscular Blocking Agents. In: Kharkevich, D.A. (eds) New Neuromuscular Blocking Agents. Handbook of Experimental Pharmacology, vol 79. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70682-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-70682-0_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70684-4
Online ISBN: 978-3-642-70682-0
eBook Packages: Springer Book Archive